CBTp for people with treatment refractory schizophrenia on clozapine: a systematic review and meta-analysis.

CBTp may lead to small benefits for positive symptoms refractory to clozapine. Given the low risks associated with CBTp, and the limited alternative options for clozapine refractory schizophrenia, this approach should be considered in this population.